<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Lab-on-a-chip</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Advanced Biomed sells Hong Kong subsidiary for $23k </title>
      <description>
        <![CDATA[Advanced Biomed Inc. reported Dec. 30 the sale of its wholly owned Hong Kong subsidiary, Advanced Biomed (HK) Ltd., and related intellectual property to buyer Wei Ha Hui for $23,000.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727303</guid>
      <pubDate>Wed, 31 Dec 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727303-advanced-biomed-sells-hong-kong-subsidiary-for-23k</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Advanced-Biomeds-APerfusc-3D-cell-culture-system-(hero)-12-31.webp?t=1767210422" type="image/jpeg" medium="image" fileSize="256616">
        <media:title type="plain">Advanced Biomed’s A+Perfusc 3D cell culture system</media:title>
        <media:description type="plain">Advanced Biomed’s A+Perfusc 3D cell culture system
</media:description>
      </media:content>
    </item>
    <item>
      <title>Toilets could be the next big health device: Medical Korea 2025</title>
      <description>
        <![CDATA[Seung-min Park, professor at Nanyang Technological University and cofounder of Kanaria Health, is working to manufacture smart bidets that can capture biomarker data from urine and stool automatically and enable continuous monitoring.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717994</guid>
      <pubDate>Thu, 20 Mar 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/717994-toilets-could-be-the-next-big-health-device-medical-korea-2025</link>
    </item>
    <item>
      <title>Draper helps US military battle biothreats with organ-on-a-chip</title>
      <description>
        <![CDATA[The Charles Stark Draper Laboratory Inc. has joined forces with the U.S. Department of Defense (DoD) to screen pathogens, toxins and diseases using its high-throughput organ-chip devices. As part of a concerted effort to develop new medical countermeasures against biological and chemical threats, organs-on-a-chip provide directly applicable insights into human responses and enable testing on organs developed from a diverse pool of live donors prior to human trials.]]>
      </description>
      <guid>http://www.bioworld.com/articles/521978</guid>
      <pubDate>Fri, 26 Aug 2022 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/521978-draper-helps-us-military-battle-biothreats-with-organ-on-a-chip</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2022/Draper-Predict96-organ-on-chip.webp?t=1661548310" type="image/png" medium="image" fileSize="526015">
        <media:title type="plain">Inside the Predict96 device</media:title>
        <media:description type="plain">Draper’s Predict96 is helping the U.S. Department of Defense rapidly develop and evaluate medical countermeasures against pathogens and chemical agents.</media:description>
      </media:content>
    </item>
    <item>
      <title>Biological Dynamics blood test accurately detects stage I pancreatic cancers</title>
      <description>
        <![CDATA[Biological Dynamics Inc.’s Verita platform correctly identified 96% of patients with stage I pancreatic cancer, a study in <em>Nature Communications Medicine</em> demonstrated. The platform uses protein biomarkers present in extracellular vesicles and showed an overall 71% sensitivity and 99.5% specificity in pathologically confirmed stage I and II pancreatic, ovarian and bladder cancer.]]>
      </description>
      <guid>http://www.bioworld.com/articles/517104</guid>
      <pubDate>Fri, 18 Mar 2022 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/517104-biological-dynamics-blood-test-accurately-detects-stage-i-pancreatic-cancers</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Endocrine/Pancreas-illustration.webp?t=1635186197" type="image/png" medium="image" fileSize="649346">
        <media:title type="plain">3D pancreas illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Quris partners with Merck to test AI-based safety prediction tool</title>
      <description>
        <![CDATA[Quris Technologies Ltd. has inked an agreement with Merck KGaA to assess its BioAI safety prediction platform. The partnership will compare the Quris’ artificial intelligence (AI)-based platform with traditional in vivo and in vitro approaches of evaluating drug safety concerns.]]>
      </description>
      <guid>http://www.bioworld.com/articles/516047</guid>
      <pubDate>Mon, 14 Feb 2022 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/516047-quris-partners-with-merck-to-test-ai-based-safety-prediction-tool</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/AI/Pill-in-immersive-interface.webp?t=1621455412" type="image/png" medium="image" fileSize="279752">
        <media:title type="plain">Pill in immersive interface</media:title>
      </media:content>
    </item>
    <item>
      <title>Hesperos' Human-on-a-Chip system provides insight on immune response in COVID-19</title>
      <description>
        <![CDATA[Hesperos Inc.&#39;s Human-on-a-Chip in vitro system demonstrated two types of responses of the immune system in a study conducted with Hoffman-La Roche Pharmaceuticals and the University of Central Florida. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/435548</guid>
      <pubDate>Wed, 03 Jun 2020 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/435548-hesperos-human-on-a-chip-system-provides-insight-on-immune-response-in-covid-19</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/6-3-Hesperos.webp?t=1591221794" type="image/png" medium="image" fileSize="596755">
        <media:title type="plain">Woman using Human-on-a-Chip system</media:title>
        <media:description type="plain">Human-on-a-Chip system. Credit: Hesperos Inc.</media:description>
      </media:content>
    </item>
    <item>
      <title>Hesperos' 'human-on-a-chip' in vitro system predicts in vivo results for multiple drugs</title>
      <description>
        <![CDATA[Hesperos Inc.'s human-on-a-chip in vitro model for the first time successfully predicted human response to two drugs. The multi-organ model provided new insight into the drugs' cardiotoxic effects in a study published in Nature Scientific Reports. The Orlando, Fla.-based company also recently demonstrated that its model could simultaneously measure cancer drug efficacy and off-target toxicity without animal models or human testing.]]>
      </description>
      <guid>http://www.bioworld.com/articles/345990</guid>
      <pubDate>Wed, 10 Jul 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/345990-hesperos-human-on-a-chip-in-vitro-system-predicts-in-vivo-results-for-multiple-drugs</link>
    </item>
  </channel>
</rss>
